A New Treatment for Chronic Pain Combining Neuromodulation, Computer Assisted Training and Telemonitoring
Unknown statusNot applicableNCT06306053
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic pain (CP) is a leading cause of medical disability, healthcare expenditure, and reduced psychological well-being. Given the limited mobility, travel burden, and cost, access to care can be problematic for patients suffering from this disease, driving the recent shift toward care through telehealth programs. Given the complex interrelationship of physical and psychosocial aspects related to chronic pain, in this project the investigators propose to validate and investigate the effectiveness of new integrated health interventions by combining the technique of transcranial direct current stimulation (tDCS), complementary therapies and telemonitoring. The investigators hypothesize that this novel combined approach will provide a more effective strategy to overcome the classic barriers of pharmacological treatments and access to healthcare due to lack of mobility. To do this, the investigators will rely on a previously developed integrated platform that enables effective delivery of non-pharmacological interventions and outcome assessment. Many patients do not benefit from pharmacological and invasive treatments, leading to the development of alternative therapeutic options such as non-invasive brain stimulation (e.g. tDCS) and complementary interventions to improve physical and psychological well-being. These complementary interventions reduced pain intensity and psychological distress by improving individuals' ability to manage and cope with their pain. However, due to the multiple co-occurring factors associated with chronic pain, a multidisciplinary and integrated treatment approach is challenging. Technology ecosystems can be a reliable tool to achieve such a diverse personalized approach and evaluate their results. In a previous project, the investigators developed PainRE-Life, a dynamic and integrated technology ecosystem to enable continuity of care for CP patients, including personalized applications, training tools and telemonitoring tools for outcome a…
Study details
- Official title
- A New Digital Technology-based Treatment for Chronic Pain Combining Neuromodulation, Computerassisted Training and Telemonitoring
- Conditions
- Interventions
- Combination product: tDCS+EuleriaLab
- Device: tDCS
- Other: EuleriaLab
- Sponsor
- ASST Santi Paolo e Carlo
- Collaborators
- University of Milan; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Istituto Europeo di Oncologia
- Start date
- 2024-04-01
- Primary completion
- 2026-01-31
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Italy
- Total sites listed
- 3
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients with chronic pain (Fibromyalgia, Headache, Oncological Pain) * Age \> 18; * Cognitive and motor skills sufficient to support a rehabilitation process mediated by an electronic device on a signed declaration by the clinician; -Having completed and signed the informed consent form, after a detailed explanation of the task and the tools used in the study. Exclusion Criteria: * Have started new pharmacological treatments or have changed therapies that act on pain for less than a month; * Have a brain stimulator, heart marrow stimulator or pumps for intrathecal drug delivery; * Respiratory, cardiac, metabolic or other conditions incompatible with at least 30 minutes of light or moderate intensity exercise therapy; * Aphasia, dementia, or psychiatric comorbidity interfering with communication or rehabilitation program compliance; * Severe cognitive deficits; * Blindness or severe vision problems which may interfere with the use of the tablet; * Presence of cranial bone breaches; * Recurrent seizures not being treated; * Insufficient knowledge of the Italian language and/or inability to understand verbal and written instructions; * Concomitant participation in another study or clinical trial involving rehabilitation therapy (recreational therapy, occupational therapy, physiotherapy) or administration of an investigational drug
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06306053